DUBLIN--(BUSINESS WIRE)--The "Needle Free Injection System Market Report: Trends, Forecast and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering. The future of the ...

PharmaJet’s intramuscular (IM) Needle-free Injection System - Stratis® - was used to deliver Scancell’s iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 ...

Expected Revenue Growth. What This Report Will Provide? Target Audience. Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, ...

DUBLIN--(BUSINESS WIRE)--The "Technology Landscape, Trends and Opportunities in the Global Needle Free Injection System Market" report has been added to ResearchAndMarkets.com's offering. This study ...

The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period. Growth ...

First self-administered, needle-free injection system approved by Health Canada gives access to safe, painless, cost-effective, and more sustainable drug delivery for chronic illnesses Toronto, ...

PharmaJet’s Needle-free intradermal (ID) injection device ("Tropis ® ID") will be evaluated as delivery system for the tuberculin skin test (TST) in a clinical study conducted by REDE-TB. The study ...

The MuliJector is aimed at processors looking to increase throughput, broaden their product range or update equipment to ...

Early buyers will receive 10% customization on this report. Growth in this market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needle ...

PharmaJet ®, a company focused on improving the performance and outcomes of injectables through needle-free injection technology, announced that its partner, Brazilian Tuberculosis Research Network ...